NCT07909915
Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease: A Randomized Controlled Trial
StatusNot Yet Recruiting
PhasePhase 4
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Achievement of LDL-C Target Levels.
Timeframe: 12 weeks
Secondary (1)
Treatment Tolerability and Adverse Effects
Arms and interventions
treat to targetExperimental
rosuvastatin 10 mg or atorvastatin 20 mg ( to be adjusted as per response of patinet)
Fixed doseActive comparator
fixed dose atorvastatin or rosuvastatin
Drugs: Dose adjustment of statins, no dose adjustment
Sites
1 site in 1 country
- Rehman Medical InstitutePeshawar, KPK, Pakistan